Involvement of nitrergic system in the anticonvulsant effect of the cannabinoid CB1 agonist ACEA in the pentylenetetrazole-induced seizure in mice

Epilepsy Research

Volumn 84, Issue 2-3, 2009, Pages 110-119

  Bahremand, Arash ^a   Nasrabady, Sara Ebrahimi ^a   Shafaroodi, Hamed ^b   Ghasemi, Mehdi ^a   Dehpour, Ahmad Reza ^a  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b ISLAMIC AZAD UNIVERSITY   (Iran)

Author keywords

ACEA; Cannabinoid CB1 receptor; Clonic seizure threshold; Mice; Nitric oxide; Pentylenetetrazole

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 7 NITROINDAZOLE; AMINOGUANIDINE; ARACHIDONYL 2' CHLOROETHYLAMIDE; ARGININE; CANNABINOID; CANNABINOID 1 RECEPTOR AGONIST; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE; PENTETRAZOLE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTICONVULSANT ACTIVITY; ARTICLE; CLONIC SEIZURE; CONTROLLED STUDY; DRUG POTENTIATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEIZURE THRESHOLD;

ANALYSIS OF VARIANCE; ANIMALS; ANIMALS, INBRED STRAINS; ANTICONVULSANTS; ARACHIDONIC ACIDS; ARGININE; BRAIN; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENZYME INHIBITORS; MALE; MICE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; PENTYLENETETRAZOLE; PIPERIDINES; PYRAZOLES; RECEPTOR, CANNABINOID, CB1; SEIZURES;

EID: 64149109740     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2009.01.003     Document Type: Article

References (89)

1. Al-Shabanah O.A., Alam K., Nagi M.N., Al-Rikabi A.C., and Al-Bekairi A.M. Protective effect of aminoguanidine, a nitric oxide synthase inhibitor, against carbon tetrachloride induced hepatotoxicity in mice. Life Sci. 66 (2000) 265-270
2. Alexander C.B., Ellmore T.M., Kokate T.G., and Kirkby R.D. Further studies on anti- and proconvulsant effects of inhibitors of nitric oxide synthase in rodents. Eur. J. Pharmacol. 344 (1998) 15-25
3. 9-THC-induced central nervous system effects in the mouse. Eur. J. Neurosci. 13 (2001) 561-568
4. Bahremand A., Shafaroodi H., Ghasemi M., Nasrabady S.E., Gholizadeh S., and Dehpour A.R. The cannabinoid anticonvulsant effect on pentylenetetrazole-induced seizure is potentiated by ultra-low dose naltrexone in mice. Epilepsy Res. 81 (2008) 44-51
5. G-nitroarginine methyl ester, an inhibitor of nitric oxide synthase, upon the anticonvulsive activity of conventional antiepileptic drugs against maximal electroshock in mice. J. Neural Transm. 105 (1998) 1-12
6. Burette A., Zabel U., Weinberg R.J., Schmidt H.H., and Valtschanoff J.G. Synaptic localization of nitric oxide synthase and soluble guanylyl cyclase in the hippocampus. J. Neurosci. 22 (2002) 8961-8970
7. Chen K., Ratzliff A., Hilgenberg L., Gulyas A., Freund T.F., Smith M., Dinh T.P., Piomelli D., Mackie K., and Soltesz I. Long-term plasticity of endocannabinoid signaling induced by developmental febrile seizures. Neuron 39 (2003) 599-611
8. Consroe P., Martin A., and Singh V. Antiepileptic potential of cannabidiol analogs. J. Clin. Pharmacol. 21 (1981) 428S-436S
9. Consroe P., Benedito M.A., Leite J.R., Carlini E.A., and Mechoulam R. Effects of cannabidiol on behavioral seizures caused by convulsant drugs or current in mice. Eur. J. Pharmacol. 83 (1982) 293-298
10. Dawson V.L., and Dawson T.M. Nitric oxide in neurodegeneration. Prog. Brain Res. 118 (1998) 215-229
11. Del-Bel E.A., Oliveira P.R., Oliveira J.A., Mishra P.K., Jobe P.C., and Garcia-Cairasco N. Anticonvulsant and proconvulsant roles of nitric oxide in experimental epilepsy models. Braz. J. Med. Biol. Res. 30 (1997) 971-979
12. Deshpande L.S., Blair R.E., Ziobro J.M., Sombati S., Martin B.R., and DeLorenzo R.J. Endocannabinoids block status epilepticus in cultured hippocampal neurons. Eur. J. Pharmacol. 558 (2007) 52-59
13. 1 receptor antagonists cause status epilepticus-like activity in the hippocampal neuronal culture model of acquired epilepsy. Neurosci. Lett. 411 (2007) 11-16
14. Dewey W.L. Cannabinoid pharmacology. Pharmacol. Rev. 38 (1986) 151-178
15. Eells J.B., Clough R.W., Browning R.A., and Jobe P.C. Comparative fos immunoreactivity in the brain after forebrain, brainstem, or combined seizures induced by electroshock, pentylenetetrazol, focally induced and audiogenic seizures in rats. Neuroscience 123 (2004) 279-292
16. El-Remessy A.B., Khalil I.E., Matragoon S., Abou-Mohamed G., Tsai N.J., Roon P., Caldwell R.B., Caldwell R.W., Green K., and Liou G.I. Neuroprotective effect of (_)delta9-tetrahydrocannabinol and cannabidiol in N-methyl-d-aspartate-induced retinal neurotoxicity: involvement of peroxynitrite. Am. J. Pathol. 163 (2003) 1997-2008
17. 1 receptor-mediated inhibition of inducible nitric oxide synthase protein expression in C6 rat glioma cells. J. Neurochem. 78 (2001) 835-841
18. Ghasemi M., Sadeghipour H., Mani A.R., Tavakoli S., Hajrasouliha A.R., Ebrahimi F., and Dehpour A.R. Effect of anandamide on nonadrenergic noncholinergic-mediated relaxation of rat corpus cavernosum. Eur. J. Pharmacol. 544 (2006) 138-145
19. 1 receptors. BJU Int. 100 (2007) 1385-1390
20. Ghasemi M., Sadeghipour H., Shafaroodi H., Nezami B.G., Gholipour T., Hajrasouliha A.R., Tavakoli S., Nobakht M., Moore K.P., Mani A.R., and Dehpour A.R. Role of the nitric oxide pathway and the endocannabinoid system in neurogenic relaxation of corpus cavernosum from biliary cirrhotic rats. Br. J. Pharmacol. 151 (2007) 591-601
21. Gholizadeh S., Shafaroodi H., Ghasemi M., Bahremand A., Sharifzadeh M., and Dehpour A.R. Ultra-low dose cannabinoid antagonist AM251 enhances cannabinoid anticonvulsant effects in the pentylenetetrazole-induced seizure in mice. Neuropharmacology 53 (2008) 763-770
22. 1 receptor. J. Neurosci. 17 (1997) 5327-5333
23. Hájos N., Ledent C., and Freund T.F. Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus. Neuroscience 106 (2001) 1-4
24. Hara S., Kuriiwa F., Iwata N., Mukai T., Kano S., and Endo T. Distinct effects of N omega-nitro-l-arginine on seizures induced by several drugs in mice. Pharmacol. Biochem. Behav. 53 (1996) 673-677
25. Hayase T., Yamamoto Y., and Yamamoto K. Protective effects of cannabinoid receptor ligands analogous to anandamide against cocaine toxicity. Nihon Arukoru Yakubutsu Igakkai Zasshi 36 (2001) 596-608
26. Herkenham M., Lynn A.B., de Costa B.R., and Richfield E.K. Neuronal localization of cannabinoid receptors in the basal ganglia of the rat. Brain Res. 547 (1991) 267-274
27. Herman B.H., Vocci F., and Bridge P. The effects of NMDA receptor antagonists and nitric oxide synthase inhibitors on opioid tolerance and withdrawal: medication development issues for opiate addiction. Neuropsychopharmacology 13 (1995) 269-293
28. 1). J. Pharmacol. Exp. Ther. 289 (1999) 1427-1433
29. Homayoun H., Khavandgar S., Namiranian K., Gaskari S.A., and Dehpour A.R. The role of nitric oxide in anticonvulsant and proconvulsant effects of morphine in mice. Epilepsy Res. 48 (2002) 33-41
30. Howlett A.C., Breivogel C.S., Childers S.R., Deadwyler S.A., Hampson R.E., and Porrino L.J. Cannabinoid physiology and pharmacology: 30 years of progress. Neuropharmacology 47 (2004) 345-358
31. 9-tetrahydrocannabinol is mediated through the inhibition of nuclear factor-κB/Rel activation. Mol. Pharmacol. 50 (1996) 334-341
32. Karler R., Cely W., and Turkanis S.A. The anticonvulsant activity of cannabidiol and cannabinol. Life Sci. 13 (1973) 1527-1531
33. 9-tetrahydrocannabinol and its 11-hydroxy and 8α, 11-dihydroxy metabolites in the frog. Res. Commun. Chem. Pathol. Pharmacol. 9 (1974) 441-452
34. 9-tetrahydrocannabinol and other cannabinoids. Life Sci. 15 (1974) 931-947
35. Karler R., Cely W., and Turkanis S.A. A study of the development of tolerance to an anticonvulsant effect of delta9-tetrahydrocannabinol and cannabidiol. Res. Commun. Chem. Pathol. Pharmacol. 9 (1974) 23-39
36. Kim S.H., Won S.J., Mao X.O., Jin K., and Greenberg D.A. Molecular mechanisms of cannabinoid protection from neuronal excitotoxicity. Mol. Pharmacol. 69 (2005) 691-696
37. Kim S.H., Won S.J., Mao X.O., Ledent C., Jin K., and Greenberg D.A. Role for neuronal nitric-oxide synthase in cannabinoid-induced neurogenesis. J. Pharmacol. Exp. Ther. 319 (2006) 150-154
38. Kirkby R.D., Carroll D.M., Grossman A.B., and Subramaniam S. Factors determining proconvulsant and anticonvulsant effects of inhibitors of nitric oxide synthase in rodents. Epilepsy Res. 24 (1996) 91-100
39. Knowles R.G., and Moncada S. Nitric oxide as a signal in blood vessels. Trends Biochem. Sci. 17 (1992) 399-402
40. Koch M., Habazettl I., Dehghani F., and Korf H.W. The rat pineal gland comprises an endocannabinoid system. J. Pineal Res. 45 4 (2008) 351-360
41. Kreitzer A.C., and Regehr W.G. Cerebellar depolarization-induced suppression of inhibition is mediated by endogenous cannabinoids. J. Neurosci. 21 1-5 (2001) RC174
42. Lambert D.M., Vandevoorde S., Diependaele G., Govaerts S.J., and Robert A.R. Anticonvulsant activity of N-palmitoylethanolamide, a putative endocannabinoid, in mice. Epilepsia 42 (2001) 321-327
43. Lapin I.P., Mirzaev S.M., Ryazov I.V., and Oxenkrug G.F. Anticonvulsant activity of melatonin against seizures induced by quinolinate, kainate, glutamate, NMDA, and pentylenetetrazole in mice. J. Pineal Res. 24 (1998) 215-218
44. Lauretti G.R., Ahmad I., and Pleuvry B.J. The activity of opioid analgesics in seizure models utilizing N-methyl-dl-aspartic acid, kainic acid, bicuculline and pentylenetetrazole. Neuropharmacology 33 (1994) 155-160
45. 1 receptor knockout mice. Science 283 (1999) 401-404
46. Licinio J., Prolo P., McCann S.M., and Wong M.L. Brain iNOS: current understanding and clinical implications. Mol. Med. Today 5 (1999) 225-232
47. Lisson P., Resentini M., Mauri R., Esposti D., Rossi D., Legname G., and Fraschini F. Effects of tetrahydrocannabinol on melatonin secretion in man. Horm. Metab. Res. 18 (1986) 77-78
48. Löscher W., Honack D., Fassbender C.P., and Nolting B. The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs. III. Pentylenetetrazole seizure models. Epilepsy Res. 8 (1991) 171-189
49. Löscher W., and Lehmann H. L-deprenyl (selegiline) exerts anticonvulsant effects against different seizure types in mice. J. Pharmacol. Exp. Ther. 277 (1996) 1410-1417
50. Lothman E.W., Bertram III E.H., and Stringer J.L. Functional anatomy of hippocampal seizures. Prog. Neurobiol. 37 (1991) 1-82
51. 1 receptor agonist, enhances the anticonvulsant action of valproate in the mouse maximal electroshock-induced seizure model. Eur. J. Pharmacol. 547 (2006) 65-74
52. Maccarrone M., Fiori A., Bari M., Granata F., Gasperi V., De Stefano M.E., Finazzi-Agro A., and Strom R. Regulation by cannabinoid receptors of anandamide transport across the blood-brain barrier and through other endothelial cells. Thromb. Haemost. 95 (2006) 117-127
53. Makara J.K., Katona I., Nyíri G., Németh B., Ledent C., Watanabe M., de Vente J., Freund T.F., and Hájos N. Involvement of nitric oxide in depolarization-induced suppression of inhibition in hippocampal pyramidal cells during activation of cholinergic receptors. J. Neurosci. 27 (2007) 10211-10222
54. 9-tetrahydrocannabinol in rats. Brain Res. 839 (1999) 173-179
55. Manzanares J., Corchero J., Romero J., Fernandez-Ruiz J.J., Ramos J.A., and Fuentes J.A. Pharmacological and biochemical interactions between opioids and cannabinoids. Trends Pharmacol. Sci. 20 (1999) 287-294
56. 1 cannabinoid receptors and on-demand defense against excitotoxicity. Science 302 (2003) 84-88
57. 9-tetrahydrocannabinol in rats. Pharmacol. Biochem. Behav. 2 (1974) 227-233
58. Medina J.H., and Izquierdo I. Retrograde messengers, long-term potentiation and memory. Brain Res. Brain Res. Rev. 21 (1995) 185-194
59. Moezi L., Rezayat M., Samini M., Shafaroodi H., Mehr S.E., Ebrahimkhani M.R., and Dehpour A.R. Potentiation of anandamide effects in mesenteric beds isolated from bile duct-ligated rats: role of nitric oxide. Eur. J. Pharmacol. 486 (2004) 53-59
60. Molina-Holgado F., Pinteaux E., Moore J.D., Molina-Holgado E., Guaza C., Gibson R.M., and Rothwell N.J. Endogenous interleukin-1 receptor antagonist mediates anti-inflammatory and neuroprotective actions of cannabinoids in neurons and glia. J. Neurosci. 23 (2003) 6470-6474
61. Moncada S., and Higgs A. The l-arginine-nitric oxide pathway. N. Engl. J. Med. 329 (1993) 2002-2012
62. Niaki S.E., Shafaroodi H., Ghasemi M., Shakiba B., Fakhimi A., and Dehpour A.R. Mouth breathing increases the pentylenetetrazole-induced seizure threshold in mice: a role for ATP-sensitive potassium channels. Epilepsy Behav. 13 (2008) 284-289
63. Nidhi G., Balakrishnan S., and Pandhi P. Role of nitric oxide in electroshock and pentylenetetrazole seizure threshold in rats. Methods Find. Exp. Clin. Pharmacol. 21 (1999) 609-612
64. O'Dell T.J., Hawkins R.D., Kandel E.R., and Arancio O. Tests of the roles of two diffusible substances in long-term potentiation: evidence for nitric oxide as a possible early retrograde messenger. Proc. Natl. Acad. Sci. U.S.A. 88 (1991) 11285-11289
65. Ohno-Shosaku T., Maejima T., and Kano M. Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals. Neuron 29 (2001) 729-738
66. Osonoe K., Mori N., Suzuki K., and Osonoe M. Antiepileptic effects of inhibitors of nitric oxide synthase examined in pentylenetetrazol-induced seizures in rats. Brain Res. 663 (1994) 338-340
67. Paul V., and Subramanian E.H. Evidence for an involvement of nitric oxide and gamma aminobutyric acid in the anticonvulsant action of l-arginine on picrotoxin-induced convulsions in rats. Pharmacol. Biochem. Behav. 72 (2002) 515-519
68. Paul V. The effect of N-nitro-l-arginine methyl ester posttreatment on the anticonvulsant effect of phenobarbitone and diazepam on picrotoxin-induced convulsions in rats. Pharmacol. Biochem. Behav. 74 (2003) 789-794
69. Piomelli D., Giuffrida A., Calignano A., and Rodriguez de Fonseca F. The endocannabinoid system as a target for therapeutic drugs. Trends Pharmacol. Sci. 21 (2000) 218-224
70. Prast H., and Philippu A. Nitric oxide as modulator of neuronal function. Prog. Neurobiol. 64 (2001) 51-68
71. Przegalinski E., Baran L., and Siwanowicz J. The role of nitric oxide in chemically- and electrically-induced seizures in mice. Neurosci. Lett. 217 (1996) 145-148
72. Sarkisian M.R. Overview of the current animal models for human seizure and epileptic disorders. Epilepsy Behav. 2 (2001) 201-216
73. Shafaroodi H., Ghasemi M., and Dehpour A.R. Elevation of pentylenetetrazole-induced seizure threshold in cholestatic mice: interaction between opioid and cannabinoid systems. J. Gastroenterol. Hepatol. 23 (2008) e251-e257
74. Shafaroodi H., Samini M., Moezi L., Homayoun H., Sadeghipour H., Tavakoli S., Hajrasouliha A.R., and Dehpour A.R. The interaction of cannabinoids and opioids on pentylenetetrazole-induced seizure threshold in mice. Neuropharmacology 47 (2004) 390-400
75. Stefano G.B., Liu Y., and Goligorsky M.S. Cannabinoid receptors are coupled to nitric oxide release in invertebrate immunocytes, microglia, and human monocytes. J. Biol. Chem. 271 (1996) 19238-19242
76. Stefano G.B., Salzet B., Rialas C.M., Pope M., Kustka A., Neenan K., Pryor S., and Salzet M. Morphine- and anandamide-stimulated nitric oxide production inhibits presynaptic dopamine release. Brain Res. 763 (1997) 63-68
77. Stefano G.B., Rialas C.M., Deutsch D.G., and Salzet M. Anandamide amidase inhibition enhances anandamide-stimulated nitric oxide release in invertebrate neural tissues. Brain Res. 793 (1998) 341-345
78. Stefano G.B., Salzet M., Magazine H.I., and Bilfinger T.V. Antagonism of LPS and IFN-γ induction of iNOS in human saphenous vein endothelium by morphine and anandamide by nitric oxide inhibition of adenylate cyclase. J. Cardiovasc. Pharmacol. 31 (1998) 813-820
79. Tsuda M., Suzuki T., and Misawa M. Aggravation of DMCM-induced seizure by nitric oxide synthase inhibitors in mice. Life Sci. 60 (1997) PL339-343
80. Twitchell W., Brown S., and Mackie K. Cannabinoids inhibit N- and P/Q-type calcium channels in cultured rat hippocampal neurons. J. Neurophysiol. 78 (1997) 43-50
81. G-nitro-l-arginine, a nitric oxide synthase inhibitor, and seizure susceptibility in four seizure models in mice. J. Neural Transm. 103 (1996) 1145-1152
82. Uzum G., Akgun-Dar K., Bahcekapili N., Diler A.S., and Ziylan Y.Z. Nitric oxide involvement in seizures elicited by pentylentetrazol and sex dependence. Int. J. Neurosci. 115 (2005) 1503-1514
83. Waksman Y., Olson J.M., Carlisle S.J., and Cabral G.A. The central cannabinoid receptor (CB1) mediates inhibition of nitric oxide production by rat microglial cells. J. Pharmacol. Exp. Ther. 288 (1999) 1357-1366
84. Wallace M.J., Martin B.R., and DeLorenzo R.J. Evidence for a physiological role of endocannabinoids in the modulation of seizure threshold and severity. Eur. J. Pharmacol. 452 (2002) 295-301
85. Wallace M.J., Blair R.E., Falenski K.W., Martin B.R., and DeLorenzo R.J. The endogenous cannabinoid system regulates seizure frequency and duration in a model of temporal lobe epilepsy. J. Pharmacol. Exp. Ther. 307 (2003) 129-137
86. Wendland B., Schweizer F.E., Ryan T.A., Nakane M., Murad F., Scheller R.H., and Tsien R.W. Existence of nitric oxide synthase in rat hippocampal pyramidal cells. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 2151-2155
87. Wilson R.I., Kunos G., and Nicoll R.A. Presynaptic specificity of endocannabinoid signaling in the hippocampus. Neuron 31 (2001) 453-462
88. Wilson R.I., and Nicoll R.A. Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 410 (2001) 588-592
89. 1 receptor knockout mice. Proc. Natl. Acad. Sci. U.S.A. 96 (1999) 5780-5785